Skip to main content
NASDAQ:KALA

Kala Pharmaceuticals SEC Filings & 10K Form

$5.06
-0.03 (-0.59 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.00
$5.40
50-Day Range
$5.09
$8.15
52-Week Range
$4.90
$14.68
Volume3.08 million shs
Average Volume2.37 million shs
Market Capitalization$327.09 million
P/E RatioN/A
Dividend YieldN/A
Beta0.43

SEC Filings

Kala Pharmaceuticals (NASDAQ:KALA) SEC Filings

DateFilerForm TypeView
05/05/2021
6:04 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2021
6:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2021
7:03 AM
Kala Pharmaceuticals (Filer)
Form DEFA14A
04/28/2021
7:00 AM
Kala Pharmaceuticals (Filer)
Form DEF 14A
04/05/2021
3:31 PM
Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
4:35 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:10 PM
Kala Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2021
6:01 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
3:53 PM
Kala Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
01/07/2021
6:02 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
3:53 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
3:50 PM
Iwicki Mark T (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
3:48 PM
Kala Pharmaceuticals (Issuer)
Reumuth Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
6:01 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2020
7:36 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:32 PM
Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:30 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:28 PM
Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:24 PM
Iwicki Mark T (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:22 PM
Kala Pharmaceuticals (Issuer)
Reumuth Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2020
6:03 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
6:30 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
6:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2020
8:58 PM
Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:54 PM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:51 PM
Kala Pharmaceuticals (Issuer)
Paull Robert Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:48 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:47 PM
Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:36 PM
Kala Pharmaceuticals (Issuer)
KOVEN ANDREW I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:31 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:25 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:05 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2020
3:06 PM
Kala Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/11/2020
3:58 PM
Kala Pharmaceuticals (Issuer)
Reumuth Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
7:10 AM
Kala Pharmaceuticals (Filer)
Form DEFA14A
05/26/2020
7:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
11:15 PM
Kala Pharmaceuticals (Filer)
Form EFFECT
05/07/2020
4:21 PM
Kala Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/07/2020
6:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
7:54 AM
Kala Pharmaceuticals (Filer)
Form DEFA14A
04/29/2020
7:50 AM
Kala Pharmaceuticals (Filer)
Form DEF 14A
04/13/2020
7:38 AM
Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
6:30 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2020
3:43 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
4:46 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
6:59 AM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
5:47 PM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
5:45 PM
Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:19 PM
Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
03/10/2020
8:26 PM
Kala Pharmaceuticals (Filer)
Form 424B5
03/10/2020
8:03 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2020
5:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
4:24 PM
Kala Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2020
6:15 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
6:30 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
3:06 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:19 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
4:56 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
4:56 PM
Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:05 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:28 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
3:03 PM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:02 PM
Kala Pharmaceuticals (Issuer)
PERRY GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:02 PM
Kala Pharmaceuticals (Issuer)
Paull Robert Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:02 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:01 PM
Kala Pharmaceuticals (Issuer)
KOVEN ANDREW I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:01 PM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
9:41 AM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:36 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
6:06 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
3:08 PM
Kala Pharmaceuticals (Filer)
Form DEFA14A
04/12/2019
3:02 PM
Kala Pharmaceuticals (Filer)
Form DEF 14A
03/12/2019
7:42 AM
Kala Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2019
7:32 AM
Kala Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2019
3:56 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2019
9:16 AM
Hadley Harbor Master Investors L.P. (0001641080) (Filed by)
Kala Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2019
8:57 AM
Kala Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/07/2019
6:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
4:05 PM
Iwicki Mark T (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
4:04 PM
Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
4:03 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
4:02 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:02 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
4:07 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
3:01 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
8:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
3:19 PM
Kala Pharmaceuticals (Subject)
Longitude Capital Partners II, LLC (Filed by)
Form SC 13D
10/11/2018
3:11 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
3:46 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:34 PM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:33 PM
Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:31 PM
Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
10/05/2018
5:01 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
4:26 PM
Kala Pharmaceuticals (Filer)
Form 424B2
10/02/2018
4:26 PM
Kala Pharmaceuticals (Filer)
Form 424B2
10/02/2018
3:40 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
3:38 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
6:30 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2018
11:15 PM
Kala Pharmaceuticals (Filer)
Form EFFECT
This page was last updated on 5/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.